Summary
The Warfarin versus Aspirin in Reduced Cardiac Ejection Fraction Trial [WARCEF; NCT00041938] found no compelling evidence to use warfarin for all patients according to outcomes from the study.
- Cerebrovascular Disease
- Heart Failure Clinical Trials
- Cerebrovascular Disease
- Ischemia
- © 2012 MD Conference Express®